Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Indian J Ophthalmol ; 71(1): 242-248, 2023 01.
Article in English | MEDLINE | ID: mdl-36588244

ABSTRACT

Purpose: Orbital cellulitis is a serious condition with potentially severe complications. Treatment requires interdisciplinary care and early introduction of antimicrobial therapy. In our tertiary center, a team of pediatricians, pediatric ophthalmologists, and otorhinolaryngologists successfully participated in the management of pediatric periorbital/orbital cellulitis. This study aimed to demonstrate our interdisciplinary approach and to investigate clinical profile and management of pediatric periorbital/orbital cellulitis. Methods: A retrospective chart review was performed of all pediatric patients hospitalized for periorbital and orbital cellulitis in a tertiary hospital center from September 15, 2016, to March 15, 2020. Results: A total of 26 children-median age 2.7 years (range 0.5-12)-were treated during the study period. Disease presentation was unilateral, mainly during winter (n = 12) and autumn (n = 12), without ophthalmoplegia/proptosis. Seven patients had orbital cellulitis (Chandler classification of ≥III) and were older (6.5 years, P = 0.011) with sinusitis (P < 0.001), required surgery (P = 0.004), underwent longer antimicrobial treatment (13 days, P < 0.001), and had a longer length of hospital stay (13.43 days, P = 0.001). Orbital cellulitis occurred in a median of three days (range 1-12) of acute rhinosinusitis. Radiological survey was performed in 11 patients, whereas six patients were treated surgically. All intraoperatively collected cultures (sinus swabs) were positive, whereas Streptococcus pyogenes and Peptostreptococcus were isolated in five cases. All patients fully recovered. No recurrence was documented. Conclusion: Sinusitis is associated with severe orbital cellulitis and surgical management. Orbital cellulitis occurred early in the course of acute rhinosinusitis, as a distinctive presentation of rhinosinusitis. Interdisciplinary care and early management are crucial in treatment of pediatric periorbital/orbital cellulitis.


Subject(s)
Exophthalmos , Eye Diseases , Orbital Cellulitis , Orbital Diseases , Sinusitis , Child , Humans , Infant , Child, Preschool , Orbital Cellulitis/diagnosis , Orbital Cellulitis/etiology , Orbital Cellulitis/therapy , Retrospective Studies , Sinusitis/complications , Sinusitis/diagnosis , Sinusitis/therapy , Acute Disease , Eye Diseases/complications , Anti-Bacterial Agents/therapeutic use , Orbital Diseases/diagnosis , Orbital Diseases/etiology , Orbital Diseases/therapy
2.
Surg Neurol Int ; 13: 488, 2022.
Article in English | MEDLINE | ID: mdl-36447897

ABSTRACT

Background: Papillary tumor of the pineal region (PTPR) represents a rare and histologically distinct subgroup of tumors originating in the pineal region. Few pediatric cases have been reported so far in the literature; therefore, clinical data are scarce. Case Description: We describe a case of PTPR in a 9-year-old girl who presented with a 5-month history of excessive appetite and weight gain. The patient underwent neuroimaging procedures and total gross surgical resection with postoperative adjuvant local radiotherapy, which from our experience was the best treatment choice as an attempt to avoid local recurrence. During 78-month follow-up, the patient from our study manifested no disease recurrence. Conclusion: PTPR should be included in the differential diagnosis of pineal region masses.

3.
Acta Clin Croat ; 61(4): 711-716, 2022 Dec.
Article in English | MEDLINE | ID: mdl-37868175

ABSTRACT

Acute acalculous cholecystitis (AAC) is a rare disease, particularly in children. The clinical and laboratory presentation of AAC is variable. The diagnosis is based on radiological criteria. AAC is an atypical and rare complication of Epstein-Barr virus (EBV) infection, therefore we present a girl with AAC and cholestasis due to EBV primary infection. Conservative treatment and careful monitoring was followed by clinical, radiological and laboratory improvement, and finally complete recovery. Our aim was to highlight the importance of recognizing AAC as a differential diagnosis in children with abdominal pain and/or acute cholestasis.


Subject(s)
Acalculous Cholecystitis , Cholecystitis, Acute , Cholestasis , Epstein-Barr Virus Infections , Child , Female , Humans , Child, Preschool , Epstein-Barr Virus Infections/complications , Epstein-Barr Virus Infections/diagnosis , Herpesvirus 4, Human , Acalculous Cholecystitis/complications , Acalculous Cholecystitis/diagnosis , Cholecystitis, Acute/complications , Cholestasis/etiology , Cholestasis/complications
4.
J Pediatr Gastroenterol Nutr ; 64(6): 925-929, 2017 06.
Article in English | MEDLINE | ID: mdl-27906800

ABSTRACT

OBJECTIVES: Beneficial therapeutic effect of probiotics has been reported in children with the irritable bowel syndrome (IBS) but not consistently in other functional abdominal pain-related disorders. The aim of the present study was to investigate the effect of Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain (FAP) and IBS in children. METHODS: Children (age 4-18 years) referred to pediatric gastroenterologist at Children's Hospital Zagreb from May 2012 to December 2014, diagnosed as FAP or IBS, were randomized to receive L reuteri DSM 17938 108 CFU daily or placebo. The study was a prospective, randomized, double-blind, placebo-controlled parallel study. Symptoms were evaluated using Wong-Baker FACES pain rating scale for pain and Bristol scale for stool shape and consistence. RESULTS: Data were analyzed for 55 children (26 in the intervention group and 29 in the placebo group). Children in the intervention group had significantly more days without pain (median 89.5 vs 51 days, P = 0.029). Abdominal pain was less severe in children taking probiotics during the second month (P < 0.05) and fourth month (P < 0.01). The 2 groups did not differ in the duration of abdominal pain, stool type, or absence from school. Both groups experienced significant reduction in the severity of abdominal pain from first to fourth month, with the reduction more prominent in the intervention group (P < 0.001 vs P = 0.004). CONCLUSIONS: Administration of L reuteri DSM 17938 was associated with a possible reduction of the intensity of pain and significantly more days without pain in children with FAP and IBS.


Subject(s)
Abdominal Pain/therapy , Irritable Bowel Syndrome/therapy , Limosilactobacillus reuteri , Probiotics/therapeutic use , Adolescent , Child , Child, Preschool , Chronic Disease , Double-Blind Method , Female , Follow-Up Studies , Humans , Male , Prospective Studies , Recurrence , Severity of Illness Index , Treatment Outcome
5.
Lijec Vjesn ; 138(3-4): 93-8, 2016.
Article in English, Croatian | MEDLINE | ID: mdl-30146855

ABSTRACT

Inflammatory bowel disease (IBD) is a chronic disease of the digestive system that occurs in one third of cases in childhood and adolescence. In the majority of patients IBD persists and relapses more or less frequently during their whole life and therefore pediatric patients, at some point, are transferred to the adult health care where autonomy and responsibility are required. However, adolescents with infl ammatory bowel disease are mostly insuffi ciently competent in respect to disease specifi c knowledge and self-management skills what can lead to poor disease outcome. Therefore, to enable adolescent patients continuing healthcare and bridging the gap between pediatric and adult services, gain independence and manage disease without parental assistance, structured and organized transition (transitional care) is required, whereby for a defi ned period of time health care is provided by both pediatricians and internal medicine specialists. That kind of care is carried out in many developed countries through transition clinics which have been organized for patients with a wide spectrum of chronic diseases, IBD included. The aim of this review is to investigate current organizational aspects of the transition care for adolescents with chronic diseases, namely IBD, and to present the published experience in the developed European countries. The fi nal goal is to justify organization of the transition care for IBD patients in Zagreb and to provide methods of the implementation of this kind of care in Zagreb.


Subject(s)
Inflammatory Bowel Diseases , Patient Care Management/methods , Transition to Adult Care/organization & administration , Adolescent , Europe , Humans , Inflammatory Bowel Diseases/epidemiology , Inflammatory Bowel Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...